Gene · 8900
Papers2,123
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,123
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anastellin impacts on the processing of extracellular matrix fibronectin and stimulates release of cytokines from coronary artery smooth muscle cells. | Sci Rep | 2022 | 36543832 | PubTator, text mining | PubMed |
| The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo. | Front Pharmacol | 2022 | 36532747 | PubTator, text mining | PubMed |
| Cellular functions and molecular mechanisms of ubiquitination in osteosarcoma. | Front Oncol | 2022 | 36530999 | PubTator, text mining | PubMed |
| Upregulated YTHDF1 associates with tumor immune microenvironment in head and neck squamous cell carcinomas. | Transl Cancer Res | 2022 | 36523307 | PubTator, text mining | PubMed |
| Network pharmacology- and molecular docking-based approaches to unveil the pharmacological mechanisms of dihydroartemisinin against esophageal carcinoma. | Front Genet | 2022 | 36506308 | PubTator, text mining | PubMed |
| Natural Products as Anticancer Agents: Current Status and Future Perspectives. | Molecules | 2022 | 36500466 | PubTator, text mining | PubMed |
| Anticancer Activity of (±)-Kusunokinin Derivatives towards Cholangiocarcinoma Cells. | Molecules | 2022 | 36500383 | PubTator, text mining | PubMed |
| Bacterial protein MakA causes suppression of tumour cell proliferation via inhibition of PIP5K1α/Akt signalling. | Cell Death Dis | 2022 | 36473840 | PubTator, text mining | PubMed |
| TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region. | Int J Mol Sci | 2022 | 36430798 | PubTator, text mining | PubMed |
| Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer. | Cancers (Basel) | 2022 | 36428736 | PubTator, text mining | PubMed |
| Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects. | Cancers (Basel) | 2022 | 36428573 | PubTator, text mining | PubMed |
| The roles of ING5 in cancer: A tumor suppressor. | Front Cell Dev Biol | 2022 | 36425530 | PubTator, text mining | PubMed |
| Inference of epigenetic subnetworks by Bayesian regression with the incorporation of prior information. | Sci Rep | 2022 | 36418365 | PubTator, text mining | PubMed |
| DJ-1 promotes osteosarcoma progression through activating CDK4/RB/E2F1 signaling pathway. | Front Oncol | 2022 | 36408174 | PubTator, text mining | PubMed |
| Novel gene signature reveals prognostic model in acute lymphoblastic leukemia. | Front Cell Dev Biol | 2022 | 36407095 | PubTator, text mining | PubMed |
| Analysis on internal mechanism of zedoary turmeric in treatment of liver cancer based on pharmacodynamic substances and pharmacodynamic groups. | Chin Herb Med | 2022 | 36405057 | PubTator, text mining | PubMed |
| The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer. | Cell Mol Life Sci | 2022 | 36399280 | PubTator, text mining | PubMed |
| Loss of transcription factor EB dysregulates the G1/S transition and DNA replication in mammary epithelial cells. | J Biol Chem | 2022 | 36372230 | PubTator, text mining | PubMed |
| Vitamin D in Cancer Prevention: Gaps in Current Knowledge and Room for Hope. | Nutrients | 2022 | 36364774 | PubTator, text mining | PubMed |
| Pectin: A Bioactive Food Polysaccharide with Cancer Preventive Potential. | Molecules | 2022 | 36364232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8900/papers?page=13